O'CONNELL JOSEPH P (Chief Medical Officer) received a stock award from ODONATE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/4/2020ACC: 0001209191-20-026743
Officer· Chief Medical Officer
Since Jun 2018
+78.00
Net shares
Net buyer
$933.27
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
78.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+39.00
Price / share
$23.93
Trade value
$933.27
% of position
2.0%
4/30/2020
1.91K→1.95K
Total
Net shares
+39.00
Net value
$933.27
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/30/2020 | A · Award | +39.00 | $23.93 | $933.27 | 2.0% | 1.91K | 1.95K |
| Total | +39.00 | $933.27 | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
39.00 shares
Shares
+39.00
Strike price
28.15
Held after
39.00
Exercisable
—
4/30/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock39.00 shares | 4/30/2020 | A · Award | +39.00 | 28.15 | — | 39.00 |